Search results for: NICE
Filter search results
Phill O’Neill
22 May 2014
…outputs of NICE, and benchmarking industry performance. Phill was the lead analyst for several industry and Government economic benchmarking initiatives including the Pharmaceutical Industry Competitiveness Taskforce (PICTF) Indicators, Scottish Market…
Graham Cookson
24 April 2018
…life sciences. He is best known for this work on the economics of staffing and skill mix in the English NHS, which was critical to the development of the NICE…
Simon Brassel
4 March 2019
…an estimate of the global burden of C-19, a description of the Digital Health Landscape in England and an assessment of the impact on NICE’s decisions on international HTA agencies….
Chris Skedgel
15 July 2019
…He has been a Lead Economic Reviewer for the pan-Canadian Oncology Drug Review (pCODR) and the Canadian Common Drug Review (CDR) and has led the development of NICE submissions in…
David Mott
14 August 2019
…related spillover effects, investigating patient preferences for novel treatments, and exploring societal preferences regarding health policies. Recently, his research has encompassed several key areas: understanding societal support for NICE’s severity…
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…is why alternative HTA criteria for treatments for very rare diseases have been applied through special evaluation routes, such as NICE’s Highly Specialised Technology pathway – whether those criteria are…
Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
11 April 2023
…of Health and Care Excellence (NICE), and when it is considered, the data are often much poorer than equivalent outcomes data for patients ( Pennington, 2020). There are also important…
Around The World in HTAs: Spain – Are We There Yet?
15 March 2023
…our blog about ‘HispaNICE’) The second step is to identify the long-term objectives and to design a road map towards it. This could allow the Spanish system, still in its…
A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance
19 May 2023
…such as the NICE-NHS England pilot in the UK and the PASTEUR Act in the US, is a moment of opportunity to redefine how health technologies with a large impact…